Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05020899 · ClinicalTrials.gov registry record · NA
Quit For Life (QFL): Smoking Cessation Among Chinese Smokers Living With HIV
A NA study, sponsored by Boston Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 109
- Enrollment target
NCT05020899 is a NA study that has completed, run by Boston Medical Center. The registered enrollment target is 109 participants.
The verdict
NCT05020899, a NA study, has completed, sponsored by Boston Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 109 participants
- Enrollment target
Study Summary
The purpose of this two arm randomized clinical trial (RCT) is to test if a smoking cessation program called Quit for Life (QFL) which was developed by the investigators is effective for patients in China with HIV who smoke. This program is designed to suit the needs of people with HIV who smoke in China. Eligible participants who provide consent will be randomized into either the QFL or the Control group. The QFL group will receive a quit smoking program that lasts for 8 weeks with two parts- 1. 4 sessions with a trained counselor who will discuss the participants' smoking habits and strategies to help them quit. 2. Messages sent to the participants' cell phone using WeChat. The Control group will not have sessions with a trained counselor or receive messages sent to their cell phone. Both groups will be offered nicotine replacement therapy and a self-help guide with information about quitting smoking.
Interventions
- BEHAVIORAL Sessions with a trained counselor
- OTHER Cell phone messages
- OTHER Offered nicotine replacement therapy
- OTHER Self-help guide for quitting smoking
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 109 participants |
| Start Date | 2022-02-24 |
| Est. Completion | 2023-08-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05020899
The ClinicalTrials.gov registry entry for NCT05020899 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 109 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Medical Center, which has 253 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Sessions with a trained counselor is the first listed.
NCT05020899 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05020899 about?
NCT05020899 is a clinical study titled "Quit For Life (QFL): Smoking Cessation Among Chinese Smokers Living With HIV". The purpose of this two arm randomized clinical trial (RCT) is to test if a smoking cessation program called Quit for Life (QFL) which was developed by the investigators is effective for patients in China with HIV who smoke. This program is designed to suit the needs of people with HIV who smoke in ...
What is the current status of trial NCT05020899?
This trial is currently completed. It is a NA study. The enrollment target is 109 participants. The study started on 2022-02-24. Estimated completion is 2023-08-01.
What interventions are being tested in trial NCT05020899?
The interventions under investigation include: Sessions with a trained counselor (BEHAVIORAL), Cell phone messages (OTHER), Offered nicotine replacement therapy (OTHER), Self-help guide for quitting smoking (OTHER).
Who is sponsoring clinical trial NCT05020899?
This trial is sponsored by Boston Medical Center, which has 253 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.